Targeting the Tumor Microenvironment in Renal Cell Cancer Biology and Therapy
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting the Tumor Microenvironment in Renal Cell Cancer Biology and Therapy
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-06-14
DOI
10.3389/fonc.2019.00490
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
- (2019) Brian I. Rini et al. NEW ENGLAND JOURNAL OF MEDICINE
- Activating cGAS-STING pathway for the optimal effect of cancer immunotherapy
- (2019) Anping Li et al. Journal of Hematology & Oncology
- High IDO-1 expression in tumor endothelial cells is associated with response to immunotherapy in metastatic renal cell carcinoma
- (2018) Andreas Seeber et al. CANCER SCIENCE
- Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment
- (2018) Elham Azizi et al. CELL
- First-line vascular endothelial growth factor targeted therapy in renal cell carcinoma: priming the tumor microenvironment for immunotherapy
- (2018) Nizar Tannir et al. CURRENT MEDICAL RESEARCH AND OPINION
- Contribution of Tumor Endothelial Cells in Cancer Progression
- (2018) Kyoko Hida et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Axitinib in combination with pembrolizumab in patients with advanced renal cell cancer: a non-randomised, open-label, dose-finding, and dose-expansion phase 1b trial
- (2018) Michael B Atkins et al. LANCET ONCOLOGY
- Phenotype molding of stromal cells in the lung tumor microenvironment
- (2018) Diether Lambrechts et al. NATURE MEDICINE
- Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma
- (2018) David F. McDermott et al. NATURE MEDICINE
- Endothelial Cell Metabolism in Health and Disease
- (2018) Katerina Rohlenova et al. TRENDS IN CELL BIOLOGY
- An Empirical Approach Leveraging Tumorgrafts to Dissect the Tumor Microenvironment in Renal Cell Carcinoma Identifies Missing Link to Prognostic Inflammatory Factors
- (2018) Tao Wang et al. Cancer Discovery
- The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma
- (2018) Christopher J. Ricketts et al. Cell Reports
- Targeting newly identified ERβ/TGFβ-1/SMAD3 signals with the FDA-approved antiestrogen Faslodex or an ERβ selective antagonist in renal cell carcinoma
- (2018) Wenbin Song et al. Molecular Oncology
- Vessel pruning or healing: endothelial metabolism as a novel target?
- (2017) Anna Rita Cantelmo et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors
- (2017) Frederick Arce Vargas et al. IMMUNITY
- Synergies of Targeting Tumor Angiogenesis and Immune Checkpoints in Non-Small Cell Lung Cancer and Renal Cell Cancer: From Basic Concepts to Clinical Reality
- (2017) Andreas Pircher et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Phenotypical change of tumor-associated macrophages in metastatic lesions of clear cell renal cell carcinoma
- (2017) Takanobu Motoshima et al. Medical Molecular Morphology
- Infiltrating mast cells promote renal cell carcinoma angiogenesis by modulating PI3K→AKT→GSK3β→AM signaling
- (2017) Y Chen et al. ONCOGENE
- Role of tumor microenvironment in tumorigenesis
- (2017) Maonan Wang et al. Journal of Cancer
- Tumor Infiltrating Mast Cells (TIMs) Confers a Marked Survival Advantage in Nonmetastatic Clear-Cell Renal Cell Carcinoma
- (2016) Hangcheng Fu et al. ANNALS OF SURGICAL ONCOLOGY
- Tim-3 Expression on Tumor-Infiltrating PD-1 + CD8 + T Cells Correlates with Poor Clinical Outcome in Renal Cell Carcinoma
- (2016) Clémence Granier et al. CANCER RESEARCH
- Fibroblast activation protein predicts prognosis in clear cell renal cell carcinoma
- (2016) José I. López et al. HUMAN PATHOLOGY
- Nestin expression on tumour vessels and tumour-infiltrating macrophages define a poor prognosis subgroup of pt1 clear cell renal cell carcinoma
- (2016) Jérôme Cros et al. VIRCHOWS ARCHIV
- Atezolizumab in combination with bevacizumab enhances antigen-specific T-cell migration in metastatic renal cell carcinoma
- (2016) Jeffrey J. Wallin et al. Nature Communications
- Biomarkers of evasive resistance predict disease progression in cancer patients treated with antiangiogenic therapies
- (2016) Andreas Pircher et al. Oncotarget
- Androgen receptor (AR) signaling promotes RCC progression via increased endothelial cell proliferation and recruitment by modulating AKT → NF-κB → CXCL5 signaling
- (2016) Zhenfeng Guan et al. Scientific Reports
- The Contribution of Angiogenesis to the Process of Metastasis
- (2015) Diane R. Bielenberg et al. CANCER JOURNAL
- Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses
- (2015) Katherine B. Chiappinelli et al. CELL
- Orchestration and Prognostic Significance of Immune Checkpoints in the Microenvironment of Primary and Metastatic Renal Cell Cancer
- (2015) N. A. Giraldo et al. CLINICAL CANCER RESEARCH
- Molecular Subtypes of Clear Cell Renal Cell Carcinoma Are Associated with Sunitinib Response in the Metastatic Setting
- (2015) B. Beuselinck et al. CLINICAL CANCER RESEARCH
- Modes of cancer cell invasion and the role of the microenvironment
- (2015) Andrew G Clark et al. CURRENT OPINION IN CELL BIOLOGY
- International Variations and Trends in Renal Cell Carcinoma Incidence and Mortality
- (2015) Ariana Znaor et al. EUROPEAN UROLOGY
- Predicting prognosis and therapeutic response from interactions between lymphocytes and tumor cells
- (2015) David A. Quigley et al. Molecular Oncology
- Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
- (2015) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer-associated fibroblasts promote renal cell carcinoma progression
- (2015) Yunze Xu et al. TUMOR BIOLOGY
- Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity
- (2015) Leticia Corrales et al. Cell Reports
- Prognostic and theranostic impact of molecular subtypes and immune classifications in renal cell cancer (RCC) and colorectal cancer (CRC)
- (2015) Etienne Becht et al. OncoImmunology
- Molecular Profiling Reveals a Tumor-Promoting Phenotype of Monocytes and Macrophages in Human Cancer Progression
- (2014) Manesh Chittezhath et al. IMMUNITY
- Fibroblast heterogeneity in the cancer wound
- (2014) Daniel Öhlund et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Emerging role of tumor-associated macrophages as therapeutic targets in patients with metastatic renal cell carcinoma
- (2013) Matteo Santoni et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- Clinical value of circulating endothelial cell detection in oncology
- (2012) Jaco Kraan et al. DRUG DISCOVERY TODAY
- SIX1 induces lymphangiogenesis and metastasis via upregulation of VEGF-C in mouse models of breast cancer
- (2012) Chu-An Wang et al. JOURNAL OF CLINICAL INVESTIGATION
- Levels of circulating CD45dimCD34+VEGFR2+ progenitor cells correlate with outcome in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitors
- (2011) F Farace et al. BRITISH JOURNAL OF CANCER
- Knockdown of VEGF receptor-1 (VEGFR-1) impairs macrophage infiltration, angiogenesis and growth of clear cell renal cell carcinoma (CRCC)
- (2011) Chenghai Li et al. CANCER BIOLOGY & THERAPY
- Tumor-Associated Macrophages Mediate Immunosuppression in the Renal Cancer Microenvironment by Activating the 15-Lipoxygenase-2 Pathway
- (2011) I. Daurkin et al. CANCER RESEARCH
- Macrophage infiltration and its prognostic relevance in clear cell renal cell carcinoma
- (2011) Yoshihiro Komohara et al. CANCER SCIENCE
- Vascular Endothelial Growth Factor–Targeted Therapies in Advanced Renal Cell Carcinoma
- (2011) Laurence Albiges et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Biomarkers in Tumor Angiogenesis and Anti-Angiogenic Therapy
- (2011) Andreas Pircher et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Bevacizumab can induce reactivity to VEGF-C and -D in human brain and tumour derived endothelial cells
- (2011) S. Grau et al. JOURNAL OF NEURO-ONCOLOGY
- The lymphatic vasculature in disease
- (2011) Kari Alitalo NATURE MEDICINE
- Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases
- (2011) Peter Carmeliet et al. NATURE REVIEWS DRUG DISCOVERY
- Complexity of tumor vasculature in clear cell renal cell carcinoma
- (2010) Chao-Nan Qian et al. CANCER
- Cytogenetic Abnormalities of Tumor-Associated Endothelial Cells in Human Malignant Tumors
- (2009) Tomoshige Akino et al. AMERICAN JOURNAL OF PATHOLOGY
- Increased numbers of small circulating endothelial cells in renal cell cancer patients treated with sunitinib
- (2009) Laura Vroling et al. ANGIOGENESIS
- Mast cells in tumor growth: Angiogenesis, tissue remodelling and immune-modulation
- (2009) Steven Maltby et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Role of cytokine therapy for Renal Cell Carcinoma in the era of targeted agents
- (2009) Sebastien J. Hotte et al. Current Oncology
- Angiogenesis in renal cell carcinoma: The role of tumor-associated macrophages
- (2009) Hiroshi Toge et al. INTERNATIONAL JOURNAL OF UROLOGY
- The lack of correlation between mast cells and microvessel density with pathologic feature of renal cell carcinoma
- (2009) Mohammad Ghassem Mohseni et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): A literature review
- (2008) Kiran Gupta et al. CANCER TREATMENT REVIEWS
- Sunitinib Reverses Type-1 Immune Suppression and Decreases T-Regulatory Cells in Renal Cell Carcinoma Patients
- (2008) J. H. Finke et al. CLINICAL CANCER RESEARCH
- The tumor microenvironment and its contribution to tumor evolution toward metastasis
- (2008) Girieca Lorusso et al. HISTOCHEMISTRY AND CELL BIOLOGY
- 5′-triphosphate-siRNA: turning gene silencing and Rig-I activation against melanoma
- (2008) Hendrik Poeck et al. NATURE MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation